• Pioglitazone: PPARγ Agonist Research Workflows

  2026-08-14

  Pioglitazone links metabolic transcriptional control with macrophage-polarization and tissue-protection assays. This practical guide covers compound preparation, DSS colitis workflows, beta-cell studies, neuroinflammation models, and troubleshooting strategies for more reproducible PPARγ research.

• SAR131675: VEGFR-3 Inhibition Workflows

  2026-08-14

  SAR131675 is a selective VEGFR-3 inhibitor for separating VEGFC-driven lymphatic, endothelial, and macrophage responses in cell, biochemical, and disease-model studies. This guide translates its potency, selectivity, formulation constraints, and hepatic fibrosis evidence into practical workflows and troubleshooting decisions.

• Dihydroartemisinin: Assay Design Beyond Malaria

  2026-08-13

  Dihydroartemisinin is a peroxide-containing Artemisia-derived research compound with antimalarial, mTOR-related, and inflammation-focused applications. This guide explains how to design mechanism-resolving assays and use phebestin research to strengthen interpretation without conflating distinct molecular targets.

• Tacrine hydrochloride hydrate: Assay Workflows

  2026-08-13

  Build more reproducible cholinesterase, neuronal viability, and neuroprotection experiments with Tacrine hydrochloride hydrate, using concentration-aware controls and orthogonal readouts. A metabolism-focused reference study adds a practical lesson: do not assume one enzyme pathway when parent compound and metabolite behavior may differ.

• RAB Proximity Mapping Reveals RAB14 Functions

  2026-08-12

  Gaudreault and colleagues used APEX2 proximity labeling to map proteins neighboring 23 human RAB GTPases and identify trafficking-associated functional relationships. The study highlights RAB14 links to the EARP complex and SHIP164/UHRF1BP1, while also defining a RAB25–DENND6A connection relevant to recycling endosomes.

• Cy3-dCTP for Direct DNA Labeling

  2026-08-12

  Cy3-dCTP enables direct fluorescent incorporation into DNA and cDNA for PCR, Nick Translation, and hybridization workflows. This practical guide connects reaction design, probe-generation choices, and troubleshooting with emerging lessons from structured enzymatic DNA synthesis.

• SB-505124 Hydrochloride: Research Workflows

  2026-08-11

  Translate selective ALK4/5/7 inhibition into practical assays for Smad signaling, fibroblast activation, glaucoma models, and cancer mechanobiology. This guide combines solvent handling, dose-finding, pathway readouts, and troubleshooting for more interpretable SB-505124 experiments.

• MTT Readouts for Translational GBM Research

  2026-08-11

  A mechanistic and strategic guide to using MTT as a metabolic readout in glioblastoma nanomedicine studies, with practical controls, translational limitations, and a framework for connecting cell viability data to immune-cycle outcomes.

• Tranexamic Acid Workflows for Clot Stability

  2026-08-10

  Build reproducible clot-stabilization, plasmin, and cell-adhesion assays with Tranexamic Acid, an antifibrinolytic agent suited to mechanistic fibrinolysis research. Translate the published NO–Tranexamic Acid–propolis dressing design into practical formulation screens while keeping antibacterial effects and antifibrinolytic effects analytically separate.

• CCG-1423: Rethinking RhoA Pathway Translation

  2026-08-09

  RhoA signaling is not a single switch but a layered network spanning cytoskeletal mechanics, nuclear transcription, barrier integrity, invasion, and apoptosis. This article examines how CCG-1423 can help translational researchers separate MRTF-A nuclear signaling from RhoA/ROCK-driven contractility, using recent MVC infection findings to define opportunities, controls, and limitations.

• Alpha-2 Receptors Link Itch and Pain via the Locus Coeruleus

  2026-08-08

  The reference study identifies the descending locus coeruleus–spinal cord noradrenaline pathway as a circuit that oppositely regulates itch and pain through α2 adrenergic receptors. Its comparison of locus coeruleus noradrenergic neurons with their spinal projection provides a useful framework for interpreting circuit-specific chemogenetic and pharmacological experiments.

• CircCramp1l–HMGB1/Drp1 Axis in Allergic Rhinitis

  2026-08-07

  A 2026 Biochemical Pharmacology study identifies circCramp1l as an upstream regulator of mitochondrial dysfunction and allergic inflammation through the miR-532-3p/HMGB1/Drp1 pathway. Its combination of human tissue, HDM models, multi-omics, molecular interaction assays, and genetic and pharmacological rescue experiments provides a mechanistic framework for studying allergic rhinitis.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Signal Amplificatio

  2026-08-07

  Explore how the Cy5 Goat Anti-Rabbit IgG (H+L) Antibody empowers advanced detection in antiviral innate immunity research. This in-depth guide unpacks fluorescence signal amplification and practical protocol insights for dissecting MAVS regulation, offering a perspective beyond typical workflow articles.

• Aminopeptidase Inhibition as an Antimalarial Strategy: Insig

  2026-08-06

  The referenced study establishes phebestin, a bestatin-related aminopeptidase inhibitor, as a potent antiplasmodial agent active against both chloroquine-sensitive and -resistant Plasmodium falciparum strains. This innovation underscores aminopeptidases as validated drug targets and provides a foundation for developing therapies that may circumvent current resistance issues in malaria.

• SAR131675: VEGFR-3 Inhibitor for Advanced Fibrosis & Cancer

  2026-08-06

  SAR131675 enables precise, high-selectivity targeting of VEGFR-3-driven lymphangiogenesis and angiogenesis, unlocking robust modeling in fibrotic and oncology research. Its nanomolar potency and protocol-proven selectivity streamline both mechanistic and translational workflows, as highlighted by recent breakthroughs in hepatic fibrosis and tumor microenvironment studies.

15682 records 1/1046 page Next 12345 下5页 Last page